Tirzepatide is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management
Medical and nutritional science continually evolves, and what is considered best practice today might change as new evidence comes to light
Working with an endocrinologist for the first time, she decided that birth control the typical first-line treatment for PCOS was not for her, and tried to treat her condition with diet, exercise, supplements and progesterone pills to try to force her period to come
Any consideration of adding a GLP-1 agonist must occur under close rheumatologist supervision, particularly if weight loss or glycemic goals are also present
10.1016/j.bbagen.2014.12.001 Biochim Biophys Acta
Therefore, we use another high performing method named Sigmoid-SVM method instead of normalized POLY-SVM in comparison